NCT03156842View on ClinicalTrials.gov

Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia

PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

May 29, 2017

Primary Completion Date

December 7, 2018

Study Completion Date

December 7, 2018

Conditions
Essential HypertensionDyslipidemia
Interventions
DRUG

Fimasartan/Amlodipine, Rosuvastatin

"A fixed dose combination tablet of Fimasartan and Amlodipine and Rosuvastatin will be administrated once daily on treatment period."

DRUG

Fimasartan/Amlodipine

"A fixed dose combination tablet of Fimasartan and Amlodipine will be administrated once daily on treatment period."

DRUG

Fimasartan, Rosuvastatin

"Fimasartan and Rosuvastatin will be administrated once daily on treatment period."

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY